Balendra, R., Moens, T. G., & Isaacs, A. M. (2017). Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies. EMBO Mol Med.
Chicago Style aipamenaBalendra, Rubika, Thomas G. Moens, and Adrian M. Isaacs. "Specific Biomarkers for C9orf72 FTD/ALS Could Expedite the Journey Towards Effective Therapies." EMBO Mol Med 2017.
MLA aipamenaBalendra, Rubika, Thomas G. Moens, and Adrian M. Isaacs. "Specific Biomarkers for C9orf72 FTD/ALS Could Expedite the Journey Towards Effective Therapies." EMBO Mol Med 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.